跳至主要内容
临床试验/ISRCTN61674768
ISRCTN61674768已完成未知

Chinese herbs in treatment of acute asthma: a multicentre randomised, double-blind, placebo-controlled trial

West China Hospital at Sichuan University (China)0 个研究点目标入组 240 人开始时间: 2010年7月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
240

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Mild to moderate asthma in acute exacerbation
  • 2. Male and female patients between 15 and 75 years
  • 3. Within 72 hours of onset of acute asthma
  • 4. Ability to provide written informed consent

排除标准

  • 1. Use of systemic steroids or immunosuppressive agents within one month before recruitment, or history of life-threatening asthma requiring treatment with intubation and mechanical ventilation
  • 2. Maintenance therapy with symbicort, or rescue therapy with formoterol or anticholinergic agents
  • 3. Allergies to any components Yi-Qi-Pin-Chuan granule, as Chinese medicine
  • 4. Current alcoholism or drug abuse
  • 5. Lung diseases other asthma
  • 6. Severe diseases of cardiovascular, hepatic, renal, central nervous system, haematopoietic system cancer
  • 7. Significant medical illness (other than asthma) that is not stable
  • 8. History of respiratory tract infection within the previous 6 weeks
  • 9. Pregnancy or breastfeeding
  • 10. The inability to understand and complete this study
  • 11. Peptic ulcer or gastrointestinal haemorrhage
  • 12. Intolerance to beta-2-agonists or steroids

研究者

发起方
West China Hospital at Sichuan University (China)

相似试验